You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Federal Non-Insured Health Benefits (NIHB) Program

Who is Eligible

Registered First Nations and recognized Inuit people may be eligible for this program. Visit Who is eligible for the Non-Insured Health Benefits Program for details. 

What is Covered

General benefit

The following medications are covered under general benefit:

  • Azathioprine
  • Prednisone
  • Cyclophosphamide

Limited Use benefit

Medications covered as limited use benefit require prior approval. Have community pharmacy contact Drug Exception Center to request Limited Use Request Form. Complete form and send to the Drug Exception Center. The following medication(s) are covered under Limited Use benefit:

Exception drug benefit

Medications covered as an exception drug benefit require prior approval. Have community pharmacy contact Drug Exception Center to request Exception Drugs Request Form. Complete form and send to the Drug Exception Center.  The following medications may be covered as an exception drug benefit for GN indications:

  • Cyclosporine
  • Mycophenolate sodium
  • Mycophenolate mofetil
  • Tacrolimus immediate release
  • Tacrolimus extended release
  • Rituximab for nephrotic syndrome

Disclaimer: The information contained herein (“Information”) is intended for informational purposes only, and no warranty as to its accuracy is provided or implied. The Information was collected from third party sources and is subject to change without notice. Cancer Care Ontario (CCO) makes no warranty that the Information is current. The Information is intended for use by healthcare professionals to advise patients of drug funding options that may be available to them. Do not act or rely upon the Information without exercising your independent judgment or seeking the advice of a qualified professional. Anyone using the Information does so at his or her own risk. The drug funding options described on this website are managed and funded by third parties, not by CCO. Please direct any inquiries to the applicable agency/entity who manages the drug funding option.